WIELISA ANTI-GBM TEST SYSTEM— 510(k) K974169

Substantially Equivalent

Wieslab AB

FDA 510(k) clearance K974169 for WIELISA ANTI-GBM TEST SYSTEM, Substantially Equivalent on 1998-02-17. Applicant: Wieslab AB.

Clearance details

Applicant
Wieslab AB
Product code
Code DBL
Advisory panel
Immunology
Date received
Decision date
Decision
Substantially Equivalent
Clearance type
Traditional
Location
Frederick, MD, US
Download summary PDFView on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.